Gene therapy

This photo provided by Novartis shows Zolgensma. The one-time gene therapy developed by Novartis, Zolgensma, will cost $2.125 million. It treats a rare condition called spinal muscular atrophy, or SMA, which strikes about 400 babies born in the U.S. each year. The therapy, given in a one-hour infusion, was approved for children under age 2 and will be available within two weeks. (Novartis via AP)
May 24, 2019 - 5:51 pm
U.S. regulators have approved the most expensive medicine ever, for a rare disorder that destroys a baby's muscle control and kills nearly all of those with the most common type of the disease within a couple of years. The treatment is priced at $2.125 million. Out-of-pocket costs for patients will...
Read More
This photo provided by Novartis shows Zolgensma. The one-time gene therapy developed by Novartis, Zolgensma, will cost $2.125 million. It treats a rare condition called spinal muscular atrophy, or SMA, which strikes about 400 babies born in the U.S. each year. The therapy, given in a one-hour infusion, was approved for children under age 2 and will be available within two weeks. (Novartis via AP)
May 24, 2019 - 2:35 pm
U.S. regulators have approved the most expensive medicine ever, for a disorder that destroys a baby's muscle control and kills nearly all of those with the most common variant of the disease within a couple years. The treatment is priced at $2.125 million. Out-of-pocket costs for patients will vary...
Read More
May 24, 2019 - 1:41 pm
U.S. regulators have approved the most expensive medicine ever, a therapy meant to cure a disorder that rapidly destroys a baby's muscle control and kills most within a couple years. The one-time gene therapy developed by Novartis, Zolgensma (zohl-JEN-smah), will cost $2.125 million. It treats a...
Read More
FILE- In this Nov. 20, 2018, file photo an American flag flies outside New York Stock Exchange. Stocks are opening broadly higher on Wall Street following reports that the U.S. and China are getting closer to a deal on trade. Technology stocks, industrial and internet companies were among the biggest gainers in early trading Monday, March 4, 2019. (AP Photo/Mary Altaffer, File)
March 04, 2019 - 5:03 pm
Health care companies led stocks lower on Wall Street Monday as investors waited for more details on reports that the U.S. and China are moving closer to a deal to resolve their costly trade dispute. The sell-off was most pronounced in sectors that have shown strong gains over the last two months,...
Read More
FILE- In this Nov. 20, 2018, file photo an American flag flies outside New York Stock Exchange. Stocks are opening broadly higher on Wall Street following reports that the U.S. and China are getting closer to a deal on trade. Technology stocks, industrial and internet companies were among the biggest gainers in early trading Monday, March 4, 2019. (AP Photo/Mary Altaffer, File)
March 04, 2019 - 1:43 pm
Stocks declined broadly on Wall Street Monday afternoon, knocking more than 300 points off the Dow Jones Industrial Average. Health care, technology and financial stocks took the heaviest losses. The broad sell-off came as investors waited for more details on reports that the U.S. and China are...
Read More
FILE- In this Nov. 20, 2018, file photo an American flag flies outside New York Stock Exchange. Stocks are opening broadly higher on Wall Street following reports that the U.S. and China are getting closer to a deal on trade. Technology stocks, industrial and internet companies were among the biggest gainers in early trading Monday, March 4, 2019. (AP Photo/Mary Altaffer, File)
March 04, 2019 - 12:16 pm
NEW YORK (AP) — Stocks are edging lower on Wall Street in afternoon trading as investors wait for more details on reports that the U.S. and China are moving closer to a deal to resolve their costly trade dispute. Stocks fell back in afternoon trading, erasing an early rally. The market is still...
Read More
FILE- In this Nov. 20, 2018, file photo an American flag flies outside New York Stock Exchange. Stocks are opening broadly higher on Wall Street following reports that the U.S. and China are getting closer to a deal on trade. Technology stocks, industrial and internet companies were among the biggest gainers in early trading Monday, March 4, 2019. (AP Photo/Mary Altaffer, File)
March 04, 2019 - 10:57 am
NEW YORK (AP) — Stocks are edging higher on Wall Street in morning trading following reports that the U.S. and China are moving closer to a deal to resolve their costly trade dispute. The world's two largest economies have pulled back from an immediate escalation of their damaging trade war since...
Read More
A currency trader watches computer monitors at the foreign exchange dealing room in Seoul, South Korea, Monday, March 4, 2019. Asian stocks rose Monday after news reports said Washington and Beijing are close to reaching an agreement as early as this month to end their costly tariff war. (AP Photo/Lee Jin-man)
March 04, 2019 - 10:06 am
NEW YORK (AP) — Investor hopes for a U.S.-China trade deal pushed stocks broadly higher in early trading Monday. The world's two largest economies have pulled back from an immediate escalation of their damaging trade war since they started negotiating last month. President Donald Trump postponed a...
Read More
February 25, 2019 - 4:58 pm
Stocks closed modestly higher Monday after shedding most of the gains from an early rally spurred by the Trump administration's decision to hold off on increasing tariffs on imported Chinese goods. Investors welcomed the move, which averted an escalation in the damaging trade war between the world'...
Read More
February 25, 2019 - 2:40 pm
Stocks marched higher on Wall Street Monday after President Donald Trump agreed to hold off on raising tariffs on Chinese goods, which would have escalated a damaging trade war between the world's two largest economies. Investors had been growing increasingly optimistic over the last two weeks that...
Read More

Pages